CFO appointment
Pfizer Inc. appoints Cecile Guegan as CFO
Pfizer Inc. reported in a Form 8-K filed November 3, 2026 that Cecile Guegan was appointed Chief Financial Officer, Executive Vice President, effective November 1, 2026.
In the filing's words
On November 3, 2026, Pfizer Inc. (the “Company”) announced that the Board of Directors of the Company unanimously elected Cecile Guegan to serve as Chief Financial Officer, Executive Vice President of the Company, effective November 1, 2026 (the “Effective Date”).
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | Pfizer Inc. (PFE) |
|---|---|
| Event | Appointment |
| Incoming | Cecile Guegan |
| Title in the filing | Chief Financial Officer, Executive Vice President |
| Effective | November 1, 2026 |
| 8-K filed | November 3, 2026 |
| Internal promotion | Not established by the source |
| SEC CIK | 0000078003 |
Pfizer Inc. reported this change in a Form 8-K, Item 5.02, filed November 3, 2026. The filing's own words are quoted above.
Also filed in November 2026
Other CFO moves on the record that month. All moves.
2 days ago· 2026-11-13InterimCVLT
Commvault Systems, Inc. names Danielle Abrahamsen interim CFO
2 days ago· 2026-11-13TransitionIONQ
IonQ, Inc. CFO transition: Gary Merrill to succeed Inder M. Singh
2 days ago· 2026-11-13DepartureRGS
Regis Corporation discloses CFO departure: Kersten Zupfer
3 days ago· 2026-11-12TransitionHUBS
HubSpot, Inc. CFO transition: Karen Burgess to succeed Kate Bueker
3 days ago· 2026-11-12AppointmentPROF
Profound Medical Corp. appoints Matthew Sobczyk as CFO
3 days ago· 2026-11-12TransitionQXO
QXO, Inc. CFO transition: Dev Ahuja to succeed Ihsan Essaid
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-11-03
Something wrong about Cecile Guegan? Send a correction with the primary source.